The compounds of Formula I are pro-drugs of CETP inhibitors having a central oxazolidinone ring. The compounds cyclize by the elimination of HX to form an oxazolidinone ring after administration to a patient.
式I的化合物是具有中央
噁唑烷环的CETP
抑制剂的前药。这些化合物在给患者使用后通过消除HX环化形成
噁唑烷环。